270
CLINICAL TRIALS
127
OUTCOMES RESEARCH STUDIES
25
COUNTRIES
150
CLIENTS

SERVICES

Full Product
Development Partner

figure-1-1-updated
img1
icon-1
CO-DEVELOPMENT

Cost-effective risk reduction and quality maintenance in our clients’ projects. Providing input into development and GTM strategies, facilitating fund-raising, participating in co-development and risk sharing.

READ MORE

icon-2
EARLY DEVELOPMENT

We partner with centres of excellence to drive efficient early development, getting our clients to GO/NOGO decisions faster through effective design and conduct of First-In-Human, BA/BE, Biosimilar and other early-phase studies. We have a strong network of pre-clinical services with strategic partners across the globe.

READ MORE

icon-3
PHASE II & III

Partnering with our customers to bring products to market efficiently and effectively, saving time, reducing costs and improving quality using innovative and adaptive digital technology in clinical trials.

READ MORE

img2
icon-4
CONSULTING

Our capabilities include Strategic & Needs Assessments, Study Protocol Design, Risk-Benefit Risk Management, Patient Reported Outcomes, Literature Reviews & Meta-Analyses, Biostatistics, Monitoring & Evaluation, Medical Writing & Pharmacoeconomic Training.

READ MORE

icon-5
MARKET ACCESS SOLUTIONS

Guiding our clients in creating effective market access solutions based on Needs Assessment, Pricing & Reimbursement Strategy, Health Economics, Pharmacoeconomics and Value Propositions.

READ MORE

icon-6
LATE-PHASE & POST-APPROVAL

Partnering with our clients with expert guidance to lead products through late phase research toward increased market access. Studies are innovative and practical and include Phase IV trials, Observational Studies, Registries & Retrospective Studies.

READ MORE

NEWS STAND

Latest News

Read the latest Clinical Development and Outcomes Research
articles in our News Stand.

ISTH
TCD attending the ISTH 2017 Congress in Berlin, Germany.

  The Largest International Meeting of the Thrombosis and Hemostasis Community, the ISTH 2017 Congress, is currently taking place at the CityCube/Messe Berlin in Germany. It is the 26th Biennial Congress and will run until Thursday, the 13th of July. The ISTH 2017 Congress is the foremost global meeting in thrombosis, hemostasis and vascular biology. The […]

July 12, 2017
EOH-image
TCD joins EOH as the group grows with strategic changes taking effect in May 2017

We are delighted to share the following significant changes and positive developments which took place recently within the TCD Group. New Ownership EOH, a JSE-listed South African based Knowledge Management group, have been in negotiation with the TCD Group since the last quarter of 2015, sharing the strategic objective to expand in the field of […]

May 02, 2017
Tienie Stander, CEO of TCD Outcome Research welcoming Hanaa Abdel-Maguid, Managing Director of TCD MENA and TCD MENA’s super team in the opening ceremony
TCD MENA launch a major success

The TCD MENA launch took place on Tuesday, April 4, 2017 at the JW Marriott, Hall Tutankhamun 3, Ring Road-Cairo, Egypt. The event themed, “Partners In Innovation” was well received by those attending the launch. The attendees provided positive feedback and informative suggestions on future initiatives. They included representatives from local and multinational pharmaceutical companies […]

April 26, 2017

PARTNERS

We work with

line

An eClinical Solutions Company launched in 2012 to provide EMR, EDC and mHealth solutions within clinical research.

Our service offerings will be augmented through a range of wellness and care programmes ranging from preventive screening to Home Healthcare and palliative care.

Integrium is a full-service Clinical Proof of Concept (PoC) Firm based in the US focused within a number of different therapeutic areas.